Global Liver Institute

NASH News

GLOBAL LIVER INSTITUTE

NASH News
7th Annual Global Fatty Liver Day is less than 3 months away!

7th Annual Global Fatty Liver Day is less than 3 months away!

Fatty liver disease is a widespread issue that often goes undetected until it’s too late. It impacts millions worldwide leading to missed opportunities for early intervention and prevention. Studies highlight a concerning gap in identifying patients within the healthcare system who may have fatty liver disease unknowingly. We cannot afford to overlook the silent nature of this and this is why we are advocating for immediate action.

read more
What’s next in line for fatty liver disease? – NASH News

What’s next in line for fatty liver disease? – NASH News

Madrigal Pharmaceuticals celebrates EMA’s validation of the Marketing Authorization Application for Resmetirom, a potential breakthrough therapy for NASH/MASH with liver fibrosis, while eagerly awaiting FDA’s decision, marking significant progress in the fight against liver-related mortality in Europe.

read more
Celebrating Progress and Anticipating Success in 2024

Celebrating Progress and Anticipating Success in 2024

As 2023 comes to a close, we extend our appreciation to each of you for following our monthly NASH News updates, supporting GLI’s work, and your steadfast dedication to advancing liver health. While we celebrate this year’s accomplishments, there’s more work ahead, and we eagerly anticipate another successful year in 2024.

read more
Building on Fatty Liver Awareness and Treatments

Building on Fatty Liver Awareness and Treatments

As prospects for new fatty liver and NASH treatments appear on the horizon, GLI continues to push for better awareness, screening, and treatment options. With fatty liver disease being diagnosed in a growing pediatric population, understanding the role of nutrition, risks, and the connection to co-occurring disorders is vital to addressing this chronic, progressive disease.

read more
Tackling Fatty Liver Disease

Tackling Fatty Liver Disease

As the field of NASH is on the verge of clinical and diagnostic breakthroughs, discover how GLI is promoting healthier living through our personalized nutrition solution, advocating for greater inclusion in clinical trials, and recognizing the role of drug safety and efficacy.

read more